Grippovac

Composition
The medication contains in 1ml on 20mcg hemagglutinin A subtype (H3N2) and A (H1N1) and 26mcg of B-type.

Pharmaceutical form
Is produced on 0,5ml (1 dose) and on 1,0ml (2 doses) in ampoules and on 25ml (50 doses) or on 50ml (100 doses) in bottles. The box with 10 ampoules contains 2 ampoule knives, the instruction on application; a box with a bottle – the instruction on application.

Description
An opalescent colourless liquid without extraneous impurity and inclusions

Indications
Will be applied to preventive maintenance of a flu, postinfluenzal complications, and also for simplification of a current of disease at children at the age of 7 years and is more senior at intranasal vaccine introduction, at adults, is more senior 18 years, – at intranasal or parenteral introduction.

Dosage and administration
Vaccine is injected hypodermically, unitary in volume 0,5ml by means of a syringe into area of an external surface of a shoulder on some centimeters below a humeral joint, using a preparation packaged in ampoules, or intranasally in a dose (on 0,25ml in each nasal course) twice with an interval of 21-28 days (interval lengthening for 1-2 weeks is admissible).

Manufacturers
The Saint-Petersburg scientific research institute of vaccines and the enterprise on production of the bacteriological drugs Russia).

Shelf life
1 year

Storage conditions
In a dry place, at temperature 4–8 °C. Do not freeze.